Showing results (181-190 of 314) with videos related to

Sort By:
Pageof 32
Journal of Cachexia, Sarcopenia and Muscle|April 18, 2014
Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?David R Fogelman, Holly Holmes, Khalil Mohammed, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 24, 2013
Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trialYing Guo, Desiree Jones, J Lynn Palmer, et al.
NPJ Precision Oncology|October 28, 2021
An analysis of research biopsy core variability from over 5000 prospectively collected core samplesDeepak Bhamidipati, Anuj Verma, Dawen Sui, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2017
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancerM J Overman, L Adam, K Raghav, et al.
CA: a Cancer Journal for Clinicians|June 26, 2023
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancerLauren M Janczewski, Amanda E Browner, Joseph H Cotler, et al.
Frontiers in Oncology|August 9, 2021
The Provocative Roles of Platelets in Liver Disease and CancerPreeti Kanikarla Marie, Natalie W Fowlkes, Vahid Afshar-Kharghan, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or olderJonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
Investigational New Drugs|June 12, 2015
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancerS M Reddy, S Kopetz, J Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2021
ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel AdenocarcinomaKatrina S Pedersen, Nathan R Foster, Michael J Overman, et al.
Genes, Chromosomes & Cancer|June 22, 2000
Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1S A Rasmussen, J Overman, S A Thomson, et al.
Pageof 32